Zepbound vials vs KwikPen: cost and how to order

Zepbound vials and the KwikPen cost the same when you pay cash through LillyDirect: $299 a month at 2.5 mg, $399 at 5 mg and $449 at 7.5 mg to 15 mg if you refill within 45 days (LillyDirect). The real differences are the device you use each week and coverage, since Medicare’s GLP-1 Bridge lists the KwikPen and not vials. Either one starts with a prescription from a licensed clinician.

The ways Zepbound comes

Zepbound is tirzepatide, a once-weekly injection approved for long-term weight reduction in adults with obesity, or with overweight plus at least one weight-related condition (Zepbound prescribing information, rev. 08/2026). It is also approved for moderate to severe obstructive sleep apnea in adults with obesity. The label lists several formats with the same drug inside:

• A single-dose vial holds one weekly dose, in 2.5, 5, 7.5, 10, 12.5 or 15 mg.
• A single-dose pen comes in the same six strengths.
• A multi-dose vial or KwikPen holds 4 doses.

LillyDirect’s self-pay prices cover vials and the KwikPen. For self-pay, a “month” is 4 vials or 1 KwikPen, which lasts 28 days (Lilly).

The dose schedule on the label is the same whatever the format. You start at 2.5 mg for 4 weeks (a starting dose, not a maintenance dose), then move to 5 mg. Any further increases come in 2.5 mg steps at least 4 weeks apart, up to 15 mg. Your clinician sets the pace.

The format does not change the medicine. In SURMOUNT-1, the trial behind the weight indication, people lost 15.0% of body weight on average at 5 mg, 19.5% at 10 mg and 20.9% at 15 mg over 72 weeks, vs 3.1% on placebo. Those are trial averages, not a promise.

The label also lists a single-dose pen. LillyDirect publishes self-pay prices for vials and the KwikPen, so if your insurance covers Zepbound, ask your plan which format it pays for.

Vials vs KwikPen side by side

Price does not separate the two; handling and coverage do.

Self-pay prices by dose

The $449 tier for 7.5 mg and up comes from Lilly’s self-pay program. Since February 23, 2026, it applies automatically on your first purchase at those doses. You must certify that you are using Zepbound for an FDA-approved use, and the current savings offers expire December 31, 2026 (Lilly).

The 45-day window is the detail to watch. At 10 mg, a late refill costs $699 instead of $449, which is $250 more that month.

Over a year, a 28-day month means about 13 fills. At 10 mg or higher, 13 on-time fills at $449 come to $5,837. Paying $699 each time would cost $9,087, or $3,250 more.

For context, the White House put Zepbound’s list price before rebates at $1,088 a month in February 2026 (White House). TrumpRx.gov also lists Zepbound at $299 a month, with no dose shown.

Insurance and Medicare

If you have commercial insurance that covers Zepbound, Lilly’s savings card can bring it to as little as $25 a month. Government beneficiaries are excluded. Compare providers on our GLP-1 with insurance rankings.

If you have Medicare Part D, the Medicare GLP-1 Bridge runs from July 1, 2026 to December 31, 2027 (CMS). Eligible enrollees pay $50 a month. That copay does not count toward your Part D out-of-pocket maximum, and low-income subsidies do not apply.

The format matters here. The CMS prior-authorization form lists Foundayo, Wegovy (injection, tablets and HD) and the Zepbound KwikPen (CMS form). Vials are not on it, so through the Bridge you would use the KwikPen.

The form asks about your BMI band, prediabetes, a prior heart attack or stroke, peripheral artery disease, heart failure with preserved ejection fraction, uncontrolled high blood pressure and chronic kidney disease at stage 3a or higher. If you take Zepbound for sleep apnea, it sends you to your regular Part D plan instead. Our Medicare guide has the details.

Which one should you pick?

Since the cash price is identical, base the choice on handling and coverage.

Choose vials if

You are comfortable drawing each weekly dose into a syringe. Ask the pharmacy whether syringes and needles come with your order.

Choose the KwikPen if

You would rather keep a month of doses in one pen, or you are on Medicare and going through the Bridge, which lists only the KwikPen.

Either way, follow the Instructions for Use that come with your medication. Ask your pharmacist or clinician to walk you through the technique before your first dose, and to explain what to do if you miss one.

In the weight trials, injection-site reactions were reported by 6% to 8% of people on Zepbound vs 2% on placebo. Our side effects guide has the rest of the numbers.

How to order Zepbound, step by step

1. Get a prescription from a licensed clinician. Your own doctor can prescribe Zepbound, or a telehealth service can. Vineyard, for example, charges a $150 monthly membership, helps with prior authorizations, and bills medication separately through the pharmacy (our Vineyard review). Its FAQ puts cash-pay Zepbound vials or KwikPens at $299 to $449 a month, the top price assuming on-time refills.
2. Pick your payment route: commercial insurance with the savings card, the Medicare Bridge with the KwikPen, or self-pay.
3. For self-pay, fill the prescription through LillyDirect, choose vials or the KwikPen, and certify an FDA-approved use. At 7.5 mg and up, the $449 price applies from your first purchase.
4. Set a refill reminder well inside 45 days so you keep the $449 price at 7.5 mg and up.
5. Check prices again after December 31, 2026, when the current savings offers expire.

Compare prescribers of brand-name drugs on our brand-name GLP-1 rankings.

Where compounded tirzepatide fits

Compounded tirzepatide plans list lower prices, from $125 a month at the 39 programs we rank, as of October 2026. Compounded tirzepatide is not Zepbound and not a generic of it. A compounding pharmacy prepares it, it isn’t FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality (FDA). Our compounded tirzepatide vs Zepbound guide lays out the trade-offs, and the GLP-1 cost calculator shows the monthly math for each option.

The bottom line

Pick between Zepbound vials and the KwikPen on handling and coverage, not price: LillyDirect charges the same for both, $299 to $449 a month with on-time refills. If you are on Medicare, the $50 Bridge points you to the KwikPen. If you pay cash at 7.5 mg or higher, refilling within 45 days can save you up to $250 a month. Talk to a licensed clinician about the dose and format that suit you.